HIV continuum of care: bridging cross-sectional and longitudinal analyses

被引:8
|
作者
Touloumi, Giota [1 ]
Thomadakis, Christos [1 ]
Pantazis, Nikos [1 ]
Papastamopoulos, Vasileios [2 ]
Paparizos, Vasilios [3 ]
Metallidis, Simeon [4 ]
Adamis, Georgios [5 ,6 ]
Chini, Maria [7 ]
Psichogiou, Mina [8 ]
Chrysos, Georgios [9 ]
Sambatakou, Helen [10 ]
Barbunakis, Emmanouil [11 ]
Vourli, Georgia [1 ]
Antoniadou, Anastasia [12 ]
机构
[1] Natl & Kapodistrian Univ Athens, Med Sch, Dept Hyg Epidemiol & Med Stat, Athens, Greece
[2] Evangelismos Gen Hosp Athens, Dept Internal Med 5, Div Infect Dis, Athens, Greece
[3] Natl & Kapodistrian Univ Athens, Syngros Hosp, Med Sch, AIDS Unit,Clin Venereol & Dermatol Dis, Athens, Greece
[4] Aristotle Univ Thessaloniki, AHEPA Univ Hosp, Infect Dis Unit, Internal Med Dept 1, Thessaloniki, Greece
[5] Gen Hosp Athens G Gennimatas, Dept Internal Med 1, Athens, Greece
[6] Gen Hosp Athens G Gennimatas, Infect Dis Unit, Athens, Greece
[7] Red Cross Gen Hosp, Dept Internal Med 3, Infect Dis Unit, Athens, Greece
[8] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 1, Athens, Greece
[9] Tzane Gen Hosp Piraeus, Infect Dis Unit, Athens, Greece
[10] Natl & Kapodistrian Univ Athens, Hippokration Univ Gen Hosp, Med Sch, Dept Internal Med 2,HIV Unit, Athens, Greece
[11] Univ Hosp Heraklion, Dept Internal Med, Iraklion, Crete, Greece
[12] Natl & Kapodistrian Univ Athens, Attikon Univ Gen Hosp, Med Sch, Dept Internal Med 4, Athens, Greece
关键词
cascade of care; continuum of care; HIV continuum of care; longitudinal continuum of care; lost to follow-up; time to diagnosis; INFECTION; POPULATION; PREVENTION; THERAPY; CASCADE; TIME; END;
D O I
10.1097/QAD.0000000000003131
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: The aim of this study was to propose a unified continuum-of-care (CoC) analysis combining cross-sectional and longitudinal elements, incorporating time spent between stages. Design: The established 90-90-90 target follows a cross-sectional four-stage CoC analysis, lacking information on timing of diagnosis, antiretroviral therapy (ART) initiation, and viral suppression durability. Methods: Data were derived from the Athens Multicenter AIDS Cohort Study (AMACS). In the cross-sectional CoC, we added stratification of diagnosed people with HIV (PWH) by estimated time from infection to diagnosis; of those who ever initiated ART or achieved viral suppression by corresponding current status (in 2018); and cumulative incidence function (CIF) of ART initiation and viral suppression, treating loss-to-follow-up (LTFU) as competing event. Viral suppression was defined as viral load less than 500 copies/ml. Viral suppression durability was assessed by the CIF of viral load rebound. Findings: About 89.1% of PWH in 2018 were diagnosed (range of diagnoses: 1980-2018). Median time to diagnosis was 3.5 years (IQR: 1.1-7.0). Among diagnosed, 89.1% were ever treated, of whom 86.7% remained on ART. CIF of ART initiation and LTFU before ART initiation were 80.9 and 6.0% at 5 years since diagnosis, respectively. Among treated, 89.4% achieved viral suppression, of whom 87.4% were currently virally suppressed. The CIF of viral load rebound was 24.2% at 5 years since first viral suppression but substantially reduced in more recent years. Interpretation: The proposed analysis highlights time gaps in CoC not evident by the standard cross-sectional approach. Our analysis highlights the need for early diagnosis and identifies late presenters as a key population for interventions that could decrease gaps in the CoC.
引用
收藏
页码:583 / 591
页数:9
相关论文
共 50 条
  • [31] The HIV care continuum in Latin America: challenges and opportunities
    Pineirua, Alicia
    Sierra-Madero, Juan
    Cahn, Pedro
    Guevara Palmero, Rafael Napoleon
    Martinez Buitrago, Ernesto
    Young, Benjamin
    Del Rio, Carlos
    LANCET INFECTIOUS DISEASES, 2015, 15 (07) : 833 - 839
  • [32] Cross-sectional HIV incidence estimation in an evolving epidemic
    Morrison, Doug
    Laeyendecker, Oliver
    Brookmeyer, Ron
    STATISTICS IN MEDICINE, 2019, 38 (19) : 3614 - 3627
  • [33] On the Use of Adjusted Cross-Sectional Estimators of HIV Incidence
    Wang, Rui
    Lagakos, Stephen W.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 52 (05) : 538 - 547
  • [34] Jails as an Opportunity to Increase Engagement in HIV Care: Findings from an Observational Cross-Sectional Study
    Avery, Ann K.
    Ciomcia, Rachel W.
    Lincoln, Thomas
    Desbrais, Maureen
    Jordan, Alison O.
    Rana, Aadia I.
    Machekano, Rhoderick
    AIDS AND BEHAVIOR, 2013, 17 : 137 - 144
  • [35] HIV care cost in England: a cross-sectional analysis of antiretroviral treatment and the impact of generic introduction
    Ong, K. J.
    van Hoek, A. J.
    Harris, R. J.
    Figueroa, J.
    Waters, L.
    Chau, C.
    Croxford, S.
    Kirwan, P.
    Brown, A.
    Postma, M. J.
    Gill, O. N.
    Delpech, V
    HIV MEDICINE, 2019, 20 (06) : 377 - 391
  • [36] Cascades of diabetes and hypertension care in Samoa: Identifying gaps in the diagnosis, treatment, and control continuum - a cross-sectional study
    LaMonica, Lauren C.
    McGarvey, Stephen T.
    Rivara, Anna C.
    Sweetman, Chloe A.
    Naseri, Take
    Reupena, Muagatutia Sefuiva
    Kadiamada, Hemant
    Kocher, Erica
    Rojas-Carroll, Alexa
    DeLany, James P.
    Hawley, Nicola L.
    LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2022, 18
  • [37] Transitions through the HIV continuum of care in people enrolling in care with advanced HIV disease in Latin America
    Belaunzaran-Zamudio, Pablo F.
    Rebeiro, Peter F.
    Caro-Vega, Yanink
    Castilho, Jessica
    Crabtree-Ramirez, Brenda E.
    Cesar, Carina
    Cortes, Claudia P.
    Mejia, Fernando
    Luque, Marco Tulio
    Rouzier, Vanessa
    Calvet, Guilherme
    Mcgowan, Catherine C.
    Sierra-Madero, Juan
    IJID REGIONS, 2025, 14
  • [38] Cross-sectional study of HIV prevalence and the characteristics of injecting drug users in Colombia
    Berbesi, Dedsy
    Segura, Angela
    Montoya, Liliana
    JOURNAL OF SUBSTANCE USE, 2014, 19 (05) : 364 - 367
  • [39] Prevalence of HIV Antiretroviral Drug Resistance and Its Impacts on HIV-1 Virological Failures in Jiangsu, China: A Cross-Sectional Study
    Zhou, Ying
    Lu, Jing
    Wang, Jinge
    Yan, Hongjing
    Li, Jianjun
    Xu, Xiaoqin
    Zhang, Zhi
    Qiu, Tao
    Ding, Ping
    Fu, Gengfeng
    Huan, Xiping
    Hu, Haiyang
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [40] Differences in outpatient care and treatment utilization for patients with HIV/HCV coinfection, HIV, and HCV monoinfection, a cross-sectional study
    Johnson, Terence L.
    Toliver, Joshua C.
    Mao, Lu
    Oramasionwu, Christine U.
    BMC INFECTIOUS DISEASES, 2014, 14